Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Clinical trial NCT06982274 · RECRUITING
Trial details
- NCT number
- NCT06982274
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2028-11-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.